741897
Last Update Posted: 2009-09-15
Recruiting has ended
All Genders accepted | 6 Years-11 Years |
264 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis
To determine the safety and efficacy of Fexofenadine (Telfast®) 30mg pediatric tablets on Filipino children aged 6 to 11 for the relief of symptoms associated with perennial and intermittent allergic rhinitis.
Eligibility
Relevant conditions:
Rhinitis, Allergic, Perennial
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov